长沙晚报掌上长沙5月10日讯（全媒体记者 刘军）2024年A股年报落下帷幕，超5400家上市公司披露了 2024年年报。超3000家公司实现营收正增长，近2600家公司实现归母净利润同比增长。145家披露年报 的上市湘企中，约80家公司实现营收正向增长；约60家公司实现净利润同比增长。 Choice数据显示，2024年A股上市公司营业总收入合计71.92万亿元，归母净利润合计5.21万亿元，超过 一半的上市公司实现了营收和归母净利润的双增长。银行、非银金融、石油石化等行业2024年归母净利 润总额位居前列，分别为2.14万亿元、5273.59亿元和3721.35亿元。 就上市湘企而言，2024年，湖南仅有金天钛业登陆A股市场，鹏都农牧因连续20个交易日的收盘价均低 于1元于8月30日被摘牌，上市湘企仍为146家。因*ST恒立无法按期披露年报和一季报，2024年披露年 报的上市湘企为145家。 据统计，145家湘股去年共实现营收8913.52亿元，较2023年（9249亿元）下降超3%；盈利合计420.14亿 元，同比下滑14.26%。145家湖南上市公司2024年合计赚了420.14亿元，同比下滑14.26% ...

Core Insights - The total revenue of 33 A-share listed companies in Zibo for 2024 is approximately 147.77 billion yuan, with 23 companies showing revenue growth compared to the previous year [1][2] - The total net profit for these companies is around 6.66 billion yuan, with 19 companies experiencing a year-on-year increase in net profit [1][8] Revenue Performance - 23 companies achieved positive revenue growth, while 10 companies reported declines [2] - Three companies surpassed the 10 billion yuan revenue mark: Qixiang Tengda (25.22 billion yuan), Bohui Paper (18.93 billion yuan), and Xinhua Medical (10.02 billion yuan) [2][4] - Qixiang Tengda remains the revenue leader despite a 6.31% decline in revenue [4] - Bohui Paper produced 4.53 million tons of paper, achieving a revenue of 18.93 billion yuan, a 1.27% increase [4] - Xinhua Medical's revenue increased slightly by 0.09%, with significant growth in its pharmaceutical equipment segment [4][5] Profitability Analysis - The total net profit of 33 companies is approximately 6.66 billion yuan, with notable profit leaders being Yingke Medical (1.47 billion yuan), Shandong Yaobang (943 million yuan), and Xinhua Medical (692 million yuan) [8][9] - Yingke Medical's net profit surged by 282.63%, marking it as the most profitable company [9][10] - 19 companies reported an increase in net profit, while 14 companies experienced declines [8][12] - Five companies saw net profit declines exceeding 50%, with Yahua Electronics reporting a significant loss of 26 million yuan [12][13] Notable Companies - Yingke Medical's production capacity utilization reached 100%, with a recovery in sales prices compared to 2023 [10] - Bohui Paper's strong production capacity contributed to its stable revenue growth [4] - Xinhua Medical is expanding its international presence with five overseas sales centers [5] - Blue Sail Medical, despite a revenue increase of 26.91%, reported a loss of 446 million yuan [16]

Core Viewpoint - The overall performance of A-share listed companies in 2024 remains stable, with a majority reporting profits despite a slight decline in total revenue and net profit compared to the previous year [1][2]. Group 1: Financial Performance - As of April 29, 2024, 75.49% of A-share companies reported profits, with 3961 out of 5274 companies achieving profitability [1]. - Total revenue for A-share companies reached 69.77 trillion yuan, a decrease of 0.35% year-on-year, while net profit was 5.23 trillion yuan, down 0.81% from the previous year [1]. - Approximately 2986 companies reported revenue growth, accounting for 57% of those that disclosed annual reports, with 215 companies experiencing revenue increases exceeding 50% [1][2]. Group 2: Industry Performance - In 2024, 13 out of 31 primary industries saw year-on-year revenue growth, with non-bank financials, automotive, and electronics leading the way with growth rates of 16.06%, 13.15%, and 9.32% respectively [3]. - The agriculture, forestry, animal husbandry, and fishery sector saw significant profit increases, with companies like Muyuan Foods and Wens Foodstuffs turning losses into profits, reporting net profits of 178.81 billion yuan and 92.30 billion yuan respectively [3]. Group 3: Research and Development Investment - A-share companies increased their R&D investments, totaling 1.55 trillion yuan in 2024, a 1.6% increase year-on-year [4]. - BYD led in R&D spending with 531.95 billion yuan, marking a 34.42% increase from the previous year [4]. Group 4: Top Companies - The top three companies by revenue in 2024 were Sinopec with 30,745.62 billion yuan, PetroChina with 29,379.81 billion yuan, and China State Construction with 21,871.48 billion yuan [2]. - The banking and insurance sectors dominated profitability, with the top ten companies by net profit including four major state-owned banks, led by Industrial and Commercial Bank of China at 365.86 billion yuan [2].